Thrombolysis to Recanalization Time Affects the Benefit of Bridging Thrombolysis in Large Vessel Occlusion Patients With Successful Recanalization

溶栓至血管再通时间影响大血管闭塞患者成功再通后桥接溶栓治疗的获益

阅读:1

Abstract

BACKGROUND AND PURPOSE: The benefit of bridging intravenous thrombolysis (IVT) was conflicting in patients with large vessel occlusion (LVO) who received endovascular treatment (EVT). This study aimed to determine whether IVT to recanalization time (TRT) can affect the benefit of IVT bridging EVT. METHODS: Based on a retrospective cohort, eligible LVO patients who achieved successful recanalization after IVT bridging EVT within onset to puncture time of 7 h were enrolled and were divided into TRT ≤ 182 min and TRT > 182 min groups according to median TRT. The primary outcome was the shift in the degree of disability as measured by the modified Rankin Scale (mRS) at 90 days. The primary safety outcome was symptomatic intracranial hemorrhage (sICH). The inverse propensity of treatment weight (IPTW) was used as sensitivity analysis. RESULTS: A total of 83 eligible patients were enrolled in the final analysis, including 42 in the TRT ≤ 182 min and 41 in the TRT > 182 min group. There was a shift tendency toward a lower degree of functional disability on mRS score at 90 days favoring the TRT ≤ 182 min group compared to the TRT > 182 min group (adjusted OR 1.80, 95% CI 0.69-4.75, p = 0.19), which was confirmed by IPTW analysis (OR 1.73, 95% CI 1.16-2.59, p = 0.06). A numerically higher proportion of excellent functional outcome at 90 days was found in the TRT ≤ 182 min vs. TRT > 182 min group (56.8% vs. 33.8% before IPTW; 58.4% vs. 25.9% after IPTW). There was no difference in sICH between the TRT ≤ 182 min and TRT > 182 min group. CONCLUSION: Among LVO patients who achieved successful recanalization after IVT bridging EVT, the benefit of IVT may be associated with TRT. This finding needs to be validated in prospective trials. TRIAL REGISTRATION: This trial was registered with ClinicalTrials.gov (NCT04752735).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。